Founder, President, Chief Executive Officer & Director, Transmedics
Search every verified Waleed Hassanein interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Waleed Hassanein, founder, president, and CEO of TransMedics, announced in May 2025 plans to establish a second headquarters in Mirandola, Italy, describing the location as having the technical expertise and talent pool for medical device disposables. He stated that the company will build a research and development facility for next-generation perfusion systems and later transition to manufacturing clean-room production of disposable units. Hassanein said the company has been called "the Ferrari of transplant perfusion devices" and that locating in the same region as Ferrari would "make that rumor a reality." He declined to comment on politics but said the company's mission is to help patients and save lives, adding that they will find a way to overcome geopolitical challenges. In 2022, Hassanein expressed enthusiasm for the ISHLT annual meeting returning to Boston and said TransMedics looked forward to sharing results of clinical trials involving its Organ Care System heart and lung technologies, as well as a national program structure aimed at maximizing donor organ utilization. In 2017, he described the Organ Care System as a portable device that maintains organs in a living state outside the body by perfusing them with warm, oxygenated blood, contrasting it with cold storage, which he said limits organ viability to 3-6 hours. He noted that at the time, only 2-3 out of every 10 donated organs were used with cold storage, and that TransMedics had raised close to $300 million in investment and performed more than 800 successful transplants.
“Well, it was an easy choice for us because Miranda has the technical expertise, the history, the talent pool. So for us, when we want to build an innovation center, we wanted to be in the best place for medical device disposables and perfusion disposables. Miranda was at the top of the list.”
“We will start with building a state-of-the-art innovation R&D facility focusing on our next-generation perfusion systems disposables, and then from there once we've developed the entire new platform we will transition into manufacturing as well, clean room production for all of our disposable units.”
“Our goal is to establish a second headquarters located in Miranda, Italy, that we can supply the world with transplant technologies from Boston and Miranda.”
“We've always been called the Ferrari of transplant perfusion devices, so we couldn't find a better opportunity to be in the same region with the real Ferrari. We'll make that rumor a reality.”
In questa intervista esclusiva, Waleed Hassanein, fondatore e CEO di @Transmedics , racconta la visione che ha guidato ...
Waleed Hassanein, MD, from TransMedics, is proud to be a member of the #ISHLT community, and he's especially excited for the ...
Open for more More about exceptional inventors and the European Inventor Award organised by the European Patent Office: ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Waleed Hassanein.